Litcius/Paper detail

Canakinumab Lacks Efficacy in Treating Adult Patients with Moderate to Severe Chronic Spontaneous Urticaria in a Phase II Randomized Double-Blind Placebo-Controlled Single-Center Study

Julia‐Tatjana Maul, Meike Distler, Antonios G.A. Kolios, Lara Valeska Maul, Carole Guillet, Nicole Graf, Laurence Imhof, Claudia Lang, Alexander A. Navarini, Peter Schmid‐Grendelmeier

2020The Journal of Allergy and Clinical Immunology In Practice24 citationsDOI

Topics & Concepts

CanakinumabMedicinePlaceboClinical endpointRandomizationInternal medicineRandomized controlled trialDiseaseAnakinraPathologyAlternative medicineUrticaria and Related ConditionsAutoimmune Bullous Skin DiseasesDermatology and Skin Diseases
Canakinumab Lacks Efficacy in Treating Adult Patients with Moderate to Severe Chronic Spontaneous Urticaria in a Phase II Randomized Double-Blind Placebo-Controlled Single-Center Study | Litcius